This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sensel, M G Articles by Williams, D L Search for Related Content PubMed PubMed Citation Articles by Sensel, M G Articles by Williams, D L

Reactivation of apolipoprotein II gene transcription by cycloheximide reveals two steps in the deactivation of estrogen receptor-mediated transcription.

Department of Pharmacological Sciences, State University of New York at Stony Brook 11794-8651.

ABSTRACT

In this report, we describe apolipoprotein II (apoII) gene expression in cell lines derived by stable expression of the chicken estrogen receptor in LMH chicken hepatoma cells. In cell lines expressing high levels of receptor (LMH/2A), apoII gene expression is increased by estrogen 300-fold compared with levels in the receptor-deficient parent LMH line. LMH/2A cells show apoII mRNA induction and turnover kinetics similar to those in chicken liver. Inhibition of protein synthesis with cycloheximide (CHX) or puromycin following estrogen withdrawal superinduces apoII mRNA without affecting apoII mRNA stability. Superinduction is due to an estrogen-independent reactivation of apoII gene transcription. The apoII gene can be reactivated by CHX for up to 24 h following hormone withdrawal, suggesting that the gene is in a repressed yet transcriptionally competent state. These results reveal two distinct events necessary for termination of estrogen receptor-mediated transcription. The first event, removal of hormone, is sufficient to stop transcription when translation is ongoing. The second event is revealed by the CHX-induced superinduction of apoII mRNA following hormone withdrawal. This superinduction suggests that deactivation of estrogen receptor-mediated transcription requires a labile protein. Furthermore, reactivation of apoII gene expression by CHX and estrogen is additive, suggesting that estrogen is unable to overcome repression completely. Thus, a labile protein may act to repress estrogen receptor-mediated transcription of the apoII gene.

This article has been cited by other articles:

• Miller, M. M., Jarosinski, K. W., Schat, K. A. (2005). Positive and Negative Regulation of Chicken Anemia Virus Transcription. J. Virol. 79: 2859-2868 [Abstract] [Full Text]  
• Thorngate, F. E., Rudel, L. L., Walzem, R. L., Williams, D. L. (2000). Low Levels of Extrahepatic Nonmacrophage ApoE Inhibit Atherosclerosis Without Correcting Hypercholesterolemia in ApoE-Deficient Mice. Arterioscler. Thromb. Vasc. Bio. 20: 1939-1945 [Abstract] [Full Text]  
• Morwald, S., Yamazaki, H., Bujo, H., Kusunoki, J., Kanaki, T., Seimiya, K., Morisaki, N., Nimpf, J., Schneider, W. J., Saito, Y. (1997). A Novel Mosaic Protein Containing LDL Receptor Elements Is Highly Conserved in Humans and Chickens. Arterioscler. Thromb. Vasc. Bio. 17: 996-1002 [Abstract] [Full Text]